
Leidos Hld (LDOS) Stock Forecast & Price Target
Leidos Hld (LDOS) Analyst Ratings
Bulls say
Leidos Holdings is a technology company with a positive outlook, as they are well-positioned to provide solutions in the defense, intelligence, and health management sectors for both domestic and international clients. Despite risks associated with government spending, the company has a strong backlog and significant contract wins, with a focus on growing markets through both organic and inorganic investments, including recent acquisitions. Their NorthStar 2030 strategy and focus on renewable energy and diversity initiatives further highlight their long-term growth potential and commitment to sustainable practices. Overall, Leidos Holdings has a solid track record and strong positioning in the market, making it a attractive investment opportunity in the medium to long term.
Bears say
Leidos Holdings is facing significant uncertainties in its key Health and defense portfolios, leading to a negative outlook by financial analysts. Despite a strong Q1 performance and strategic acquisitions, the company's margins are expected to decline in the near-term, and there are concerns about the normalization of VA medical exam margins and potential competition in its high-margin managed health services business. Additionally, other risks such as inflation, foreign currency exchange rates, and cyber threats also pose potential challenges for the company's future growth. Therefore, while the stock may have an attractive valuation, the combination of these factors leads to a negative outlook for the company's stock.
This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.
Leidos Hld (LDOS) Analyst Forecast & Price Prediction
Start investing in Leidos Hld (LDOS)
Order type
Buy in
Order amount
Est. shares
0 shares